Inherited Thrombophilia
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis Ltd in Critical Reviews in Clinical Laboratory Sciences
- Vol. 43 (3), 249-290
- https://doi.org/10.1080/10408360600552678
Abstract
Inherited thrombophilia can be defined as a genetically determined predisposition to the development of thromboembolic complications. Since the discovery of activated protein C resistance in 1993, several additional disorders have been described and, at present, it is possible to identify an inherited predisposition in about 60 to 70% of patients with such complications. These inherited prothrombotic risk factors include qualitative or quantitative defects of coagulation factor inhibitors, increased levels or function of coagulation factors, defects of the fibrinolytic system, altered platelet function, and hyperhomocysteinemia. In this review, the main inherited prothrombotic risk factors are analyzed from epidemiological, laboratory, clinical, and therapeutic points of view. Finally, we discuss the synergism between genetic and acquired prothrombotic risk factors in particular conditions such as childhood and pregnancy.Keywords
This publication has 108 references indexed in Scilit:
- Evidence-based care of recurrent miscarriageBest Practice & Research Clinical Obstetrics & Gynaecology, 2005
- Thrombophilia and pregnancy complicationsAmerican Journal of Obstetrics and Gynecology, 2004
- Platelet glycoprotein IIb/IIIa PlA2/PlA2homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: The Copenhagen City Heart StudyJournal of the American College of Cardiology, 2003
- A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart diseaseStatistics in Medicine, 2003
- Heritable thrombophilia and childhood thrombosisBlood Reviews, 2001
- Genetic risk factors of venous thrombosisHuman Genetics, 2001
- Lipoprotein Lp(a) and Atherothrombotic DiseaseArchives of Medical Research, 2000
- Association of two silent polymorphisms of platelet glycoprotein la/lla receptor with risk of myocardial infarction: a case-control studyThe Lancet, 1999
- Risk of recurrent venous thromboembolism in patients with the factor V Leiden (FVR506Q) mutation: effect of warfarin and prediction by precipitating factorsBritish Journal of Haematology, 1998
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994